2nd Decentralized & Hybrid Clinical Trials World Congress 2026 Europe

Redefining Clinical Research Through Decentralization, Technology, and Collaboration

Millennium Hotel and Conference Centre Gloucester London, UK

Wednesday 25th - Thursday 26th February 2026

2026 - Sponsors & Exhibitors

Spectrum Science is an award-winning, strategic platform of integrated marketing communications, clinical trial recruitment and retention, advertising, consulting, media and patient engagement services. Connected by a foundation of scientific and strategic acumen, Spectrum delivers at all points in the product and company lifecycle, across all channels, with global reach as the founder, U.S. partner and chair of Global Health Marketing & Communications (GHMC). As an independent company with end-to-end capabilities operating all together under a single P&L, Spectrum’s flexible model is purposefully designed to meet and evolve with the specific needs of health and life.

www.spectrumscience.com

The NIHR RDN is funded by the Department of Health and Social Care (DHSC) to enable the health and care system to attract, optimise and deliver research across England.

The NIHR RDN is funded by the Department of Health and Social Care (DHSC) to enable the health and care system to attract, optimise and deliver research across England. It replaced the Clinical Research Network (CRN) on 1 October 2024.

We consist of 12 Regional Research Delivery Networks (RRDNs) and a Coordinating Centre (RDNCC), working together as one organisation with joint leadership.

We contribute to NIHR’s mission to improve the health and wealth of the nation through research.

Our vision, mission and purpose
Our vision is for the UK to be a global leader in the delivery of high quality research that is inclusive, accessible, and improves health and care.

Our mission is to enable the health and care system to attract, optimise and deliver research across England.
We have 2 primary purposes:

support the successful delivery of high quality research, as an active partner
in the research system
increase capacity and capability of the research delivery infrastructure for the
future

This will:

enable more people to access health and social care research where they live
support changing population needs by delivering a wider range of research
and deliver research in areas of most need
provide support to the health and care system through research
encourage research to become a routine part of care
support economic growth by attracting investment to the UK economy

IQVIA is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries.

IQVIA is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI™, advanced analytics, the latest technologies and extensive domain expertise. With approximately 88,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide. IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific progress, in an effort to advance healthcare.

To learn more, visit www.iqvia.com.

Founded in 2011, OPEN Health unites world-class scientific, strategic, and creative expertise to solve complex challenges for biopharma.

Founded in 2011, OPEN Health unites world-class scientific, strategic, and creative expertise to solve complex challenges for biopharma. We are a flexible, global organization, creating high-performing strategic partnerships with our clients. We embrace our different perspectives and strengths to deliver innovative solutions that have a positive impact on commercial and patient outcomes.

The OPEN Health Patient Engagement practice is one of five specialty practices within the broader OPEN Health group, offering a wide range of services to help our clients achieve their patient engagement objectives utilising an evidence based, considered, patient-centric methodology. Delivered by patient engagement specialists and an in-house health psychology and behavioural science team, the OPEN Health Patient Engagement team’s offering ranges from patient insights, co-creation, patient advocacy engagement and training to tactical patient educational support, patient support programmes and branded patient ambassador programmes.

• Company website link https://www.openhealthgroup.com/what-we-do/patient-engagement/

mdgroup supports all sizes of pharma and biotech to attract, engage, and maintain patient participation in healthcare research.

mdgroup supports all sizes of pharma and biotech to attract, engage, and maintain patient participation in healthcare research. With a pioneering global ecosystem of clinical trial solutions, streamlined patient reimbursements, safe patient transport and in-home health visits - to personalised patient support, clinical equipment logistics and top-tier healthcare professional staffing placements.

Website: https://mdgroup.com/